Latent factor structure of outcome measures used in the HABIT® Mild Cognitive Impairment intervention programs

Manuscript Number: 

21-0582R2

Author(s): 
Priscilla Amofa, Melanie Chandler, Liselotte De Wit, Brittany DeFeis, Andrea M. Kurasz, Dona Locke, Vaishali Phatak, Anne Shandera-Ochsner, Glenn Smith, Gelan Ying

Disclosures

Priscilla Amofa

  • Nothing to Disclose

Melanie Chandler

  • Patents/Royalties
    Dr. Chandler receives royalties from Neuroglee as part of a licensing of know-how agreement unrelated to the completion of this manuscript.

Liselotte De Wit

  • Nothing to Disclose

Brittany DeFeis

  • Nothing to Disclose

Andrea M. Kurasz

  • Nothing to Disclose

Dona Locke

  • Patents/Royalties
    I am currently in a know-how development relationship with Neuroglee Therapeutics. I have not actually received any payment, but there are royalties that may I may receive in the future.

Vaishali Phatak

  • Nothing to Disclose

Anne Shandera-Ochsner

  • Patents/Royalties
    Dr. Shandera-Ochsner has entered into an agreement in which her know-how has been licensed by Neuroglee Therapeutics.

Glenn Smith

  • Nothing to Disclose

Gelan Ying

  • Nothing to Disclose